PTX-9908 Injection: Clinical Trials

1 trial of PTX-9908 Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow PTX-9908 Injection: new trials by email Literature Review of PTX-9908 Injection trials Research Report on PTX-9908 Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of PTX-9908 Injection for Non-resectable HCC With TACE
PTX-9908 Injection, Placebo - Carcinoma, Hepatocellular
Phase 1 / Phase 2WithdrawnTCM Biotech International Corp.2020-10-062026-10-02

Conditions studied

Carcinoma, Hepatocellular (1)

Sponsors

TCM Biotech International Corp. (1)

Countries

Taiwan (1)

Top investigators

Chien-Hung Chien-Hung, MD, PhD (1)